These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23151473)

  • 21. A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi alpha-mannosidase II.
    Wen X; Yuan Y; Kuntz DA; Rose DR; Pinto BM
    Biochemistry; 2005 May; 44(18):6729-37. PubMed ID: 15865418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AT1 receptor ligands: virtual-screening-based design with TOPP descriptors, synthesis, and biological evaluation of pyrrolidine derivatives.
    Lamanna C; Catalano A; Carocci A; Di Mola A; Franchini C; Tortorella V; Vanderheyden PM; Sinicropi MS; Watson KA; Sciabola S
    ChemMedChem; 2007 Sep; 2(9):1298-310. PubMed ID: 17628868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-mannosidase activity in stallion epididymal fluid and spermatozoa.
    Retamal CA; Dias AJ; Brasil FC; Lanzana FR; López ML
    Theriogenology; 2012 Jul; 78(2):252-62. PubMed ID: 22578623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and glycosidase inhibitory activities of 2-(aminoalkyl)pyrrolidine-3,4-diol derivatives.
    Carmona AT; Popowycz F; Gerber-Lemaire S; Rodríguez-García E; Schütz C; Vogel P; Robina I
    Bioorg Med Chem; 2003 Nov; 11(23):4897-911. PubMed ID: 14604651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative structure and aldose reductase inhibitory activity relationship of 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone derivatives.
    Ko K; Won Y
    Bioorg Med Chem; 2005 Mar; 13(5):1445-52. PubMed ID: 15698760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.
    Parenti MD; Pacchioni S; Ferrari AM; Rastelli G
    J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors.
    Bhatt HG; Patel PK
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3758-65. PubMed ID: 22546667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological properties of D- and L-1-deoxyazasugars.
    Kato A; Kato N; Kano E; Adachi I; Ikeda K; Yu L; Okamoto T; Banba Y; Ouchi H; Takahata H; Asano N
    J Med Chem; 2005 Mar; 48(6):2036-44. PubMed ID: 15771446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition mechanism exploration of quinoline derivatives as PDE10A inhibitors by in silico analysis.
    Wu Q; Gao Q; Guo H; Li D; Wang J; Gao W; Han C; Li Y; Yang L
    Mol Biosyst; 2013 Mar; 9(3):386-97. PubMed ID: 23354020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases.
    Moreno-Clavijo E; Carmona AT; Vera-Ayoso Y; Moreno-Vargas AJ; Bello C; Vogel P; Robina I
    Org Biomol Chem; 2009 Mar; 7(6):1192-202. PubMed ID: 19262940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Entamoeba histolytica: identification and partial characterization of alpha-mannosidase activity.
    Santacruz-Tinoco CE; Villagómez-Castro JC; López-Romero E
    Exp Parasitol; 2010 Apr; 124(4):459-65. PubMed ID: 20045693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.
    Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolyl oligopeptidase inhibition by N-acyl-pro-pyrrolidine-type molecules.
    Kánai K; Arányi P; Böcskei Z; Ferenczy G; Harmat V; Simon K; Bátori S; Náray-Szabo G; Hermecz I
    J Med Chem; 2008 Dec; 51(23):7514-22. PubMed ID: 19006380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Golgi mannosidase II with mannostatin A analogues: synthesis, biological evaluation, and structure-activity relationship studies.
    Li B; Kawatkar SP; George S; Strachan H; Woods RJ; Siriwardena A; Moremen KW; Boons GJ
    Chembiochem; 2004 Sep; 5(9):1220-7. PubMed ID: 15368573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms.
    Shah N; Kuntz DA; Rose DR
    Biochemistry; 2003 Dec; 42(47):13812-6. PubMed ID: 14636047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent and selective inhibition of class II alpha-D-mannosidase activity by a bicyclic sulfonium salt.
    Siriwardena A; Strachan H; El-Daher S; Way G; Winchester B; Glushka J; Moremen K; Boons GJ
    Chembiochem; 2005 May; 6(5):845-8. PubMed ID: 15800866
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.
    Ravindra GK; Achaiah G; Sastry GN
    Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of the relationship between the structural features of andrographolide derivatives and α-glucosidase inhibitory activity: a quantitative structure-activity relationship (QSAR) study.
    Moorthy NS; Ramos MJ; Fernandes PA
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):78-87. PubMed ID: 21171896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.
    Mustyala KK; Chitturi AR; Naikal James PS; Vuruputuri U
    J Recept Signal Transduct Res; 2012 Apr; 32(2):102-13. PubMed ID: 22384789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.